Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

about

A new platform for international collaboration on pharmacology and drug development: 2017 China-Canada-USA Pharmacology/Physiology Conference.

P2860

Q54338119-6EAA0177-80EB-43D3-871C-DAB228485917

P2860

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Item

http://www.wikidata.org/entity/Q52605399

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

@en

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

@nl

type

Item

label

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

@en

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

@nl

altLabel

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities

@en

prefLabel

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

@en

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

@nl

P1476

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities

@en

P2093

Yu-Feng Tong

http://www.w3.org/2001/XMLSchema#string

P2860

Zika virus impairs growth in human neurospheres and brain organoids

TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies

CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation

A novel brain-enriched E3 ubiquitin ligase RNF182 is up regulated in the brains of Alzheimer's patients and targets ATP6V0C for degradation

The recognition of ubiquitinated proteins by the proteasome

PGC-1α, mitochondrial dysfunction, and Huntington's disease

Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes

A Strategy for Modulation of Enzymes in the Ubiquitin System

Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

P2888

aps.2018.11

P304

754-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2018.11

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yufeng Tong

Rachel Harding

P577

2018-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29620053

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

5943907

http://www.w3.org/2001/XMLSchema#string

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

about

P2860

P2860

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932